Sean Lavin
Stock Analyst at BTIG
(3.08)
# 1,225
Out of 4,865 analysts
45
Total ratings
81.82%
Success rate
38.68%
Average return
Main Sectors:
Stocks Rated by Sean Lavin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $9.83 | - | 4 | Nov 5, 2024 | |
| HOLX Hologic | Downgrades: Neutral | n/a | $64.14 | - | 5 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $304.39 | +5.13% | 5 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $86.17 | - | 1 | Jan 10, 2022 | |
| ATRC AtriCure | Maintains: Buy | $42 → $48 | $32.63 | +47.10% | 3 | Feb 19, 2020 | |
| MASI Masimo | Downgrades: Neutral | n/a | $159.43 | - | 4 | Apr 16, 2019 | |
| HSDT Helius Medical Technologies | Downgrades: Neutral | n/a | $0.31 | - | 4 | Apr 16, 2019 | |
| IRTC iRhythm Technologies | Upgrades: Buy | $80 | $144.85 | -44.77% | 3 | Apr 3, 2019 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $6.99 | - | 4 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $52.54 | - | 3 | Apr 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $132.28 | - | 1 | Jan 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $101.73 | - | 1 | Nov 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $81.83 | - | 3 | May 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $73.27 | - | 4 | Feb 2, 2017 |
Tactile Systems Technology
Nov 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $9.83
Upside: -
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $64.14
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $304.39
Upside: +5.13%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $86.17
Upside: -
AtriCure
Feb 19, 2020
Maintains: Buy
Price Target: $42 → $48
Current: $32.63
Upside: +47.10%
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $159.43
Upside: -
Helius Medical Technologies
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $0.31
Upside: -
iRhythm Technologies
Apr 3, 2019
Upgrades: Buy
Price Target: $80
Current: $144.85
Upside: -44.77%
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $6.99
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $52.54
Upside: -
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $132.28
Upside: -
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $101.73
Upside: -
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $81.83
Upside: -
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $73.27
Upside: -